NANCY YARBROUGH: Open Payments
NPI 1811253131 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 47 payments from 10 companies in 2025. Trend: 2023 $669 · 2024 $505 · 2025 $1,277
Food & beverage: $1,277
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $347 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $332 |
| Madrigal Pharmaceuticals | 8 | $328 |
| GENZYME CORPORATION | 3 | $84 |
| Janssen Biotech, Inc. | 3 | $63 |
| Echosens North America, Inc. | 1 | $36 |
| CONMED Corporation | 1 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| EVOKE PHARMA, INC. | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
Products named: REZDIFFRA, ENTYVIO, RINVOQ, DUPIXENT, TREMFYA, Fibroscan, CONMED BILIARY, SKYRIZI.
Industry payments across TX — which companies pay providers there.
